FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine and covers a protective agent for neural retina cells containing a compound of general formula (1) 
or its salt as an active ingredient, a method for prevention or treatment of diseases associated with involvement of neural retina cells and application of the compound of formula (1) for prevention or treatment of the diseases associated with involvement of neural retina cells.
EFFECT: invention provides high protective and medical effect.
16 cl, 1 dwg, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZAMIDE DERIVATIVES HAVING ANTICANCER ACTIVITY, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2011 |
|
RU2565079C2 |
| HETEROCYCLIC NITROGEN-CONTAINING OR OXYGEN-CONTAINING INSECTICIDAL COMPOUNDS FORMED FROM DIALDEHYDES, AND PRODUCTION AND USE THEREOF | 2009 |
|
RU2495023C2 |
| ARGINASE INHIBITORS AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2586219C2 |
| INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITORS, PREPARATION AND USE THEREOF | 2015 |
|
RU2719428C2 |
| ERBB RECEPTOR INHIBITORS | 2019 |
|
RU2810215C2 |
| NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
| PROTEIN TYROSINE KINASE ACTIVITY INHIBITORS | 2009 |
|
RU2533827C2 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| SYNTHESIS OF CARBAMOYL PYRIDONE INHIBITORS OF HIV INTEGRASE AND INTERMEDIATE COMPOUNDS | 2009 |
|
RU2527451C2 |
| MONOCYCLIC PYRIDINE DERIVATIVE | 2014 |
|
RU2645352C2 |
